Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Structural analysis of Borrelia burgdorferi periplasmic lipoprotein BB0365 involved in Lyme disease infection.

Brangulis K, Akopjana I, Petrovskis I, Kazaks A, Jekabsons A, Jaudzems K, Viksna A, Bertins M, Tars K.

FEBS Lett. 2019 Sep 5. doi: 10.1002/1873-3468.13594. [Epub ahead of print]

PMID:
31486526
2.

Crystal structure of Borrelia burgdorferi outer surface protein BBA69 in comparison to the paralogous protein CspA.

Brangulis K, Akopjana I, Petrovskis I, Kazaks A, Tars K.

Ticks Tick Borne Dis. 2019 Aug;10(5):1135-1141. doi: 10.1016/j.ttbdis.2019.06.009. Epub 2019 Jun 11.

PMID:
31204045
3.

Crystal structure of the membrane attack complex assembly inhibitor BGA71 from the Lyme disease agent Borrelia bavariensis.

Brangulis K, Akopjana I, Petrovskis I, Kazaks A, Kraiczy P, Tars K.

Sci Rep. 2018 Jul 26;8(1):11286. doi: 10.1038/s41598-018-29651-9.

4.

Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNA.

Sominskaya I, Jansons J, Dovbenko A, Petrakova N, Lieknina I, Mihailova M, Latyshev O, Eliseeva O, Stahovska I, Akopjana I, Petrovskis I, Isaguliants M.

J Immunol Res. 2015;2015:762426. doi: 10.1155/2015/762426. Epub 2015 Nov 2.

5.

The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.

Dishlers A, Skrastina D, Renhofa R, Petrovskis I, Ose V, Lieknina I, Jansons J, Pumpens P, Sominskaya I.

Mol Biotechnol. 2015 Dec;57(11-12):1038-49. doi: 10.1007/s12033-015-9895-9.

6.

Structural and functional analysis of BB0689 from Borrelia burgdorferi, a member of the bacterial CAP superfamily.

Brangulis K, Jaudzems K, Petrovskis I, Akopjana I, Kazaks A, Tars K.

J Struct Biol. 2015 Dec;192(3):320-330. doi: 10.1016/j.jsb.2015.09.007. Epub 2015 Sep 25.

PMID:
26407658
7.

Crystal structures of the Erp protein family members ErpP and ErpC from Borrelia burgdorferi reveal the reason for different affinities for complement regulator factor H.

Brangulis K, Petrovskis I, Kazaks A, Akopjana I, Tars K.

Biochim Biophys Acta. 2015 May;1854(5):349-55. doi: 10.1016/j.bbapap.2014.12.025. Epub 2015 Jan 9.

PMID:
25582082
8.

Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

Skrastina D, Petrovskis I, Lieknina I, Bogans J, Renhofa R, Ose V, Dishlers A, Dekhtyar Y, Pumpens P.

PLoS One. 2014 Dec 1;9(12):e114006. doi: 10.1371/journal.pone.0114006. eCollection 2014.

9.

Structural characterization of CspZ, a complement regulator factor H and FHL-1 binding protein from Borrelia burgdorferi.

Brangulis K, Petrovskis I, Kazaks A, Bogans J, Otikovs M, Jaudzems K, Ranka R, Tars K.

FEBS J. 2014 Jun;281(11):2613-22. doi: 10.1111/febs.12808. Epub 2014 Apr 28.

10.

Crystal structure of the infectious phenotype-associated outer surface protein BBA66 from the Lyme disease agent Borrelia burgdorferi.

Brangulis K, Petrovskis I, Kazaks A, Tars K, Ranka R.

Ticks Tick Borne Dis. 2014 Feb;5(1):63-8. doi: 10.1016/j.ttbdis.2013.09.005. Epub 2013 Nov 15.

PMID:
24246708
11.

A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.

Sominskaya I, Skrastina D, Petrovskis I, Dishlers A, Berza I, Mihailova M, Jansons J, Akopjana I, Stahovska I, Dreilina D, Ose V, Pumpens P.

PLoS One. 2013 Sep 23;8(9):e75938. doi: 10.1371/journal.pone.0075938. eCollection 2013.

12.

Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.

Skrastina D, Petrovskis I, Petraityte R, Sominskaya I, Ose V, Lieknina I, Bogans J, Sasnauskas K, Pumpens P.

Clin Vaccine Immunol. 2013 Nov;20(11):1719-28. doi: 10.1128/CVI.00533-13. Epub 2013 Sep 4.

13.

Structure of an outer surface lipoprotein BBA64 from the Lyme disease agent Borrelia burgdorferi which is critical to ensure infection after a tick bite.

Brangulis K, Tars K, Petrovskis I, Kazaks A, Ranka R, Baumanis V.

Acta Crystallogr D Biol Crystallogr. 2013 Jun;69(Pt 6):1099-107. doi: 10.1107/S0907444913005726. Epub 2013 May 15.

PMID:
23695254
14.

Structural characterization of the Borrelia burgdorferi outer surface protein BBA73 implicates dimerization as a functional mechanism.

Brangulis K, Petrovskis I, Kazaks A, Baumanis V, Tars K.

Biochem Biophys Res Commun. 2013 May 17;434(4):848-53. doi: 10.1016/j.bbrc.2013.04.028. Epub 2013 Apr 22.

PMID:
23618869
15.

Fibronectin-binding nanoparticles for intracellular targeting addressed by B. burgdorferi BBK32 protein fragments.

Ranka R, Petrovskis I, Sominskaya I, Bogans J, Bruvere R, Akopjana I, Ose V, Timofejeva I, Brangulis K, Pumpens P, Baumanis V.

Nanomedicine. 2013 Jan;9(1):65-73. doi: 10.1016/j.nano.2012.05.003. Epub 2012 May 23.

PMID:
22633898
16.

Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity.

Mihailova M, Fiedler M, Boos M, Petrovskis I, Sominskaya I, Roggendorf M, Viazov S, Pumpens P.

Protein Expr Purif. 2006 Nov;50(1):43-8. Epub 2006 Jun 27.

PMID:
16889980
17.

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).

Mihailova M, Boos M, Petrovskis I, Ose V, Skrastina D, Fiedler M, Sominskaya I, Ross S, Pumpens P, Roggendorf M, Viazov S.

Vaccine. 2006 May 15;24(20):4369-77. Epub 2006 Mar 15.

PMID:
16574285
18.

A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies.

Geldmacher A, Skrastina D, Borisova G, Petrovskis I, Krüger DH, Pumpens P, Ulrich R.

Vaccine. 2005 Jun 10;23(30):3973-83. Epub 2005 Mar 16.

PMID:
15917119
19.

An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice.

Geldmacher A, Skrastina D, Petrovskis I, Borisova G, Berriman JA, Roseman AM, Crowther RA, Fischer J, Musema S, Gelderblom HR, Lundkvist A, Renhofa R, Ose V, Krüger DH, Pumpens P, Ulrich R.

Virology. 2004 May 20;323(1):108-19.

20.

Stop codon insertion restores the particle formation ability of hepatitis B virus core-hantavirus nucleocapsid protein fusions.

Kazaks A, Lachmann S, Koletzki D, Petrovskis I, Dislers A, Ose V, Skrastina D, Gelderblom HR, Lundkvist A, Meisel H, Borisova G, Krüger DH, Pumpens P, Ulrich R.

Intervirology. 2002;45(4-6):340-9.

PMID:
12602354
21.

Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.

Pumpens P, Razanskas R, Pushko P, Renhof R, Gusars I, Skrastina D, Ose V, Borisova G, Sominskaya I, Petrovskis I, Jansons J, Sasnauskas K.

Intervirology. 2002;45(1):24-32.

PMID:
11937768
22.

Mutilation of RNA phage Qbeta virus-like particles: from icosahedrons to rods.

Cielens I, Ose V, Petrovskis I, Strelnikova A, Renhofa R, Kozlovska T, Pumpens P.

FEBS Lett. 2000 Oct 6;482(3):261-4.

23.

Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen.

Borisova G, Borschukova Wanst O, Mezule G, Skrastina D, Petrovskis I, Dislers A, Pumpens P, Grens E.

Intervirology. 1996;39(1-2):16-22. Review.

PMID:
8957665

Supplemental Content

Loading ...
Support Center